The acute phase of Chikungunya virus disease in newborns and children (age under 18 years) requires a distinct clinical approach. Analgesic choice, timing, and restrictions differ meaningfully from adult management and must be applied carefully.
Acute phase of Chikungunya virus disease in newborns and children (age under 18 years). Arthralgia in this age group is typically mild, short-lived, and responsive to paracetamol. NSAIDs are not appropriate during the first 14 days of illness. Opioids should not be prescribed to children.
Specific NSAIDs may be considered as part of the structured regimen, but only after the first 14 days of illness have passed. The complete protocol — including which agent to use, sequencing, and the full evidence-based guidance — is available via the link below.
Full dosing, regimen sequence, and clinical decision steps are in the complete protocol.
No NSAIDs in the first 14 days of illness. Fortunately, arthralgia in children is mild, short-lived, and responsive to paracetamol.
Opioids should not be prescribed to children.
View source ↗